Correspondence
Non-responder migraine patients to a first anti-CGRP monoclonal antibody benefit from a switch to a second one
Efecto beneficioso del cambio a un segundo anticuerpo monoclonal anti-CGRP en pacientes con migraña no respondedores a un primero
Show Less
Affiliation
1
Hospital Universitario de Navarra, Pamplona
, España
*Corresponding author: Daniel Fresan Restituto. Hospital Pharmacy Service. Hospital Universitario de Navarra. Calle Irunlarrea, 3. E-31008 Pamplona.
E-mail: Danifresan@gmail.com
Rev Neurol 2023
, 76(6),
213–216;
https://doi.org/10.33588/rn.7606.2022350
